Cyclerion Therapeutics Inc
(CYCN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -58,574 | -39,762 | -20,228 | -123,008 | -96,953 |
| Depreciation Amortization | 1,827 | 1,239 | 626 | 2,700 | 2,047 |
| Accounts receivable | 1,074 | 723 | 448 | -1,474 | -1,440 |
| Accounts payable and accrued liabilities | -680 | 48 | -1,048 | -250 | 2,129 |
| Other Working Capital | -9,148 | -10,948 | -11,460 | -2,289 | -383 |
| Other Operating Activity | 7,052 | 5,299 | 2,482 | 22,106 | 14,548 |
| Operating Cash Flow | $-58,449 | $-43,401 | $-29,180 | $-102,215 | $-80,052 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,418 | -1,421 | -1,356 | -6,715 | -6,615 |
| Investing Cash Flow | $-1,418 | $-1,421 | $-1,356 | $-6,715 | $-6,615 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,509 | 3,509 | N/A | N/A | N/A |
| Common Stock Issued | 172 | 155 | 1 | 510 | 365 |
| Other Financing Activity | 24,250 | 0 | 0 | 211,061 | 211,061 |
| Financing Cash Flow | $27,931 | $3,664 | $1 | $211,571 | $211,426 |
| Exchange Rate Effect | -7 | -10 | 2 | -20 | 1 |
| Beginning Cash Position | 102,620 | 102,621 | 102,620 | N/A | N/A |
| End Cash Position | 70,677 | 61,453 | 72,087 | 102,621 | 124,760 |
| Net Cash Flow | $-31,943 | $-41,168 | $-30,533 | $102,621 | $124,760 |
| Free Cash Flow | |||||
| Operating Cash Flow | -58,449 | -43,401 | -29,180 | -102,215 | -80,052 |
| Capital Expenditure | -1,489 | -1,480 | -1,405 | -6,888 | -6,714 |
| Free Cash Flow | -59,938 | -44,881 | -30,585 | -109,103 | -86,766 |